Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

343 ARTÍCULOS , VIENDO DEL 46 AL 60

Cefixime-induced Oromandibular Dystonia in an Adult: A Case Report

Mondet L, Radoube F, Gras V, Masmoudi K.

Curr Drug Saf. 2017;12(2):123-125. doi: 10.2174/1574886312666170310095320.

Cyclosporine A induced dystonia-parkinsonism

Miklavčič P, Avčin S, Jazbec J, Vipotnik Vesnaver T, Todorova B, Trošt M, Kojović M.

J Neurol Sci. 2017 Apr 15;375:68-70. doi: 10.1016/j.jns.2017.01.043. Epub 2017 Jan 14.

The role of deep brain stimulation in Parkinson's disease: an overview and update on new developments

Fang JY, Tolleson C.

Neuropsychiatr Dis Treat. 2017 Mar 7;13:723-732. doi: 10.2147/NDT.S113998. eCollection 2017.

BCAP31-associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy

Albanyan S, Al Teneiji A, Monfared N, Mercimek-Mahmutoglu S.

Am J Med Genet A. 2017 Jun;173(6):1640-1643. doi: 10.1002/ajmg.a.38127. Epub 2017 Mar 23.

Dopa-responsive dystonia presenting with predominant hemifacial dystonia

Kim MS, Yoon JH.

Acta Neurol Belg. 2017 Dec;117(4):955-956. doi: 10.1007/s13760-017-0771-1. Epub 2017 Mar 24.

Baclofen Pumps: Uses and Complications

Woolf SM, Baum CR.

Pediatr Emerg Care. 2017 Apr;33(4):271-275. doi: 10.1097/PEC.0000000000001090.

SUCLG1-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria

El-Hattab AW, Scaglia F.

2017 Mar 30. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules

Oshima M, Deitiker P, Hastings-Ison T, Aoki KR, Graham HK, Atassi MZ.

J Neuroimmunol. 2017 May 15;306:31-39. doi: 10.1016/j.jneuroim.2017.02.014. Epub 2017 Feb 21.

AbobotulinumtoxinA: A 25-Year History

Monheit GD, Pickett A.

Aesthet Surg J. 2017 May 1;37(suppl_1):S4-S11. doi: 10.1093/asj/sjw284.

l-Dopa in dystonia: A modern perspective

Maas RPPWM, Wassenberg T, Lin JP, van de Warrenburg BPC, Willemsen MAAP.

Neurology. 2017 May 9;88(19):1865-1871. doi: 10.1212/WNL.0000000000003897. Epub 2017 Apr 7.

Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients

Ciampi E, Uribe-San-Martín R, Godoy-Santín J, Cruz JP, Cárcamo-Rodríguez C, Juri C.

Mult Scler. 2017 Nov;23(13):1791-1795. doi: 10.1177/1352458517702968. Epub 2017 Apr 11.

Symptomatic cervical myelopathy due to general dystonia: Case report and review of the literature

Gilard V, Lefaucheur R, Grangeon L, Maltête D, Perez A, Derrey S.

Rev Neurol (Paris). 2017 Jun;173(6):424-426. doi: 10.1016/j.neurol.2017.03.009. Epub 2017 Apr 12.

Determinants of neurological disease: Synthesis of systematic reviews

Krewski D, Barakat-Haddad C, Donnan J, Martino R, Pringsheim T, Tremlett H, van Lieshout P, Walsh SJ, Birkett NJ, Gomes J, Little J, Bowen S, Candundo H, Chao TK, Collins K, Crispo JAG, Duggan T, El Sherif R, Farhat N, Fortin Y, Gaskin J, Gupta P, Hersi M, Hu J, Irvine B, Jahanfar S, MacDonald D, McKay K, Morrissey A, Quach P, Rashid R, Shin S, Sikora L, Tkachuk S, Taher MK, Wang MD, Darshan S, Cashman NR.

Neurotoxicology. 2017 Jul;61:266-289. doi: 10.1016/j.neuro.2017.04.002. Epub 2017 Apr 12.

Impairments of balance, stepping reactions and gait in people with cervical dystonia

Barr C, Barnard R, Edwards L, Lennon S, Bradnam L.

Gait Posture. 2017 Jun;55:55-61. doi: 10.1016/j.gaitpost.2017.04.004. Epub 2017 Apr 4.

Carbamazepine responsive generalized dystonia in Fahr's disease

Naheed D, Mehta S, Goyal MK, Lal V.

Parkinsonism Relat Disord. 2017 Jul;40:78-79. doi: 10.1016/j.parkreldis.2017.04.007. Epub 2017 Apr 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias